For up to 30% of patients who are allergic to medical contrast dye or have a dye restriction because of other health conditions, they might find that it takes longer to get a diagnosis when it comes to life-threatening lung issues such as pulmonary embolism.

Related Keywords

Texas , United States , Michigan , Edward Castillo , Girish Nair , National Institutes Of Health , University Of Texas At Austin , Corewell Health , Royal Oak , Derived Functional Imaging , Integrated Jacobian Formulation , National Institutes ,